JP2021518116A - 細胞媒介性エキソソーム送達 - Google Patents

細胞媒介性エキソソーム送達 Download PDF

Info

Publication number
JP2021518116A
JP2021518116A JP2020549608A JP2020549608A JP2021518116A JP 2021518116 A JP2021518116 A JP 2021518116A JP 2020549608 A JP2020549608 A JP 2020549608A JP 2020549608 A JP2020549608 A JP 2020549608A JP 2021518116 A JP2021518116 A JP 2021518116A
Authority
JP
Japan
Prior art keywords
cells
cell
receptor
protein
cell according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020549608A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021518116A5 (cg-RX-API-DMAC7.html
Inventor
ジョエル・ノルディン
Original Assignee
エヴォックス・セラピューティクス・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エヴォックス・セラピューティクス・リミテッド filed Critical エヴォックス・セラピューティクス・リミテッド
Publication of JP2021518116A publication Critical patent/JP2021518116A/ja
Publication of JP2021518116A5 publication Critical patent/JP2021518116A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2020549608A 2018-03-16 2019-03-15 細胞媒介性エキソソーム送達 Pending JP2021518116A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1804291.1A GB201804291D0 (en) 2018-03-16 2018-03-16 Cell-mediated exosome delivery
GB1804291.1 2018-03-16
PCT/EP2019/056634 WO2019175428A1 (en) 2018-03-16 2019-03-15 Cell-mediated exosome delivery

Publications (2)

Publication Number Publication Date
JP2021518116A true JP2021518116A (ja) 2021-08-02
JP2021518116A5 JP2021518116A5 (cg-RX-API-DMAC7.html) 2022-03-25

Family

ID=62017765

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020549608A Pending JP2021518116A (ja) 2018-03-16 2019-03-15 細胞媒介性エキソソーム送達

Country Status (7)

Country Link
US (1) US20200407418A1 (cg-RX-API-DMAC7.html)
EP (1) EP3765526A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021518116A (cg-RX-API-DMAC7.html)
CN (1) CN112105648A (cg-RX-API-DMAC7.html)
GB (1) GB201804291D0 (cg-RX-API-DMAC7.html)
SG (1) SG11202008227UA (cg-RX-API-DMAC7.html)
WO (1) WO2019175428A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
US12312584B2 (en) 2018-10-02 2025-05-27 Exosome Therapeutics, Inc. cGMP exosome loaded therapeutics for treating sickle cell disease
WO2020106772A1 (en) * 2018-11-19 2020-05-28 Exosome Therapeutics, Inc. Exosome loaded therapeutics for the treatment of non-alcoholic steatohepatitis, diabetes mellitus type 1 and type 2, atherosclerotic cardiovascular disease, and alpha 1 antitrypsin deficiency
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020152298A1 (en) * 2019-01-24 2020-07-30 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Method for producing enzymes
WO2020191241A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US20220259617A1 (en) 2019-06-13 2022-08-18 The General Hospital Corporation Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
CN114728174A (zh) * 2019-09-24 2022-07-08 加利福尼亚大学董事会 具有异源跨膜结构域的受体
US12195723B2 (en) 2019-11-08 2025-01-14 The Broad Institute, Inc. Engineered antigen presenting cells and uses thereof
BR112023001272A2 (pt) 2020-07-24 2023-04-04 Massachusetts Gen Hospital Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células
WO2022206816A1 (zh) * 2021-03-30 2022-10-06 南京大学 一种用于治疗帕金森的rna质粒递送系统
KR102691113B1 (ko) * 2021-04-09 2024-08-02 경북대학교 산학협력단 대식세포 유래 세포외 소포체 유사체를 포함하는 모발 재생용 조성물
CN113144293A (zh) * 2021-05-17 2021-07-23 中国人民解放军总医院 负载干细胞外泌体的丝素纳米纤维水凝胶的制作工艺
GB202107182D0 (en) * 2021-05-19 2021-06-30 Evox Therapeutics Ltd Nanoparticle delivery system for production of engineered extracellular vesicles
CN113527519B (zh) * 2021-08-11 2023-01-06 呈诺再生医学科技(珠海横琴新区)有限公司 用于递送rna的靶向外泌体
US20250223584A2 (en) 2021-12-03 2025-07-10 The Broad Institute, Inc. Compositions and methods for efficient in vivo delivery
CN114107253B (zh) * 2021-12-17 2024-03-15 复旦大学附属华山医院 一种利用工程细胞进行基因编辑的系统及方法
JP2025519070A (ja) 2022-05-17 2025-06-24 エンヴェロップ セラピューティクス, インコーポレイテッド 効率的in vivo送達のための組成物および方法
WO2024077117A1 (en) * 2022-10-06 2024-04-11 Capricor, Inc. Method for making vesicles
CN116143934B (zh) * 2023-03-21 2023-07-25 诺赛联合(北京)生物医学科技有限公司 一种干细胞外泌体提取试剂盒及其应用
US12221483B1 (en) * 2024-01-30 2025-02-11 China Medical University Hospital Fusion protein and nucleic acid encoding sequence thereof, and uses of the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018015535A1 (en) * 2016-07-21 2018-01-25 Evox Therapeutics Ltd Extracellular vesicle comprising a fusion protein having fc binding capacity
WO2018039247A1 (en) * 2016-08-23 2018-03-01 The Regents Of The University Of California Proteolytically cleavable chimeric polypeptides and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018015535A1 (en) * 2016-07-21 2018-01-25 Evox Therapeutics Ltd Extracellular vesicle comprising a fusion protein having fc binding capacity
WO2018039247A1 (en) * 2016-08-23 2018-03-01 The Regents Of The University Of California Proteolytically cleavable chimeric polypeptides and methods of use thereof

Also Published As

Publication number Publication date
CN112105648A (zh) 2020-12-18
WO2019175428A1 (en) 2019-09-19
US20200407418A1 (en) 2020-12-31
SG11202008227UA (en) 2020-09-29
GB201804291D0 (en) 2018-05-02
EP3765526A1 (en) 2021-01-20

Similar Documents

Publication Publication Date Title
US20200407418A1 (en) Cell-Mediated Exosome Delivery
JP7077404B2 (ja) Rna治療薬を含むエクソソーム
CN109715211B (zh) 包含治疗性多肽的外来体
JP2025072522A (ja) 環状rna組成物及び方法
CN112334156A (zh) 用于亲和纯化的工程细胞外囊泡
US12599679B2 (en) Circular RNA compositions
EP3786177A1 (en) Modified mitochondria and use thereof
KR20190032480A (ko) 결합능을 갖는 융합 단백질을 포함하는 세포외 소포
US20210285009A1 (en) Retrotransposon-based delivery vehicle and methods of use thereof
CN121666232A (zh) 脂质纳米颗粒制剂和组合物
JP2022520285A (ja) 低酸素応答性キメラ抗原受容体
US20250120915A1 (en) Engineered delivery vesicles and uses thereof
JP2022531887A (ja) 安定化されたrna治療薬を含むエキソソーム
US20250073350A1 (en) Compositions and methods for delivering cargo to a target cell
US20250339554A1 (en) Compositions and methods for delivering cargo to a target cell
US20260034241A1 (en) Compositions and methods for in vivo expression of chimeric antigen receptors
KR20250129816A (ko) 대식세포 특이적 프로모터 및 이의 용도
AU2024376195A1 (en) Circular rna compositions
US20250241955A1 (en) Engineered bifunctional receptors and uses thereof
EP4412627A1 (en) Enhancing adoptive cell transfer by promoting a superior population of adaptive immune cells
CN116916940A (zh) 工程化嵌合融合蛋白组合物及其使用方法
WO2025134168A1 (en) Genetically modified immune cells for the treatment of tumors and autoimmune diseases
US20260115228A1 (en) Chimeric Antigen Receptors Targeting CD19
US20260007610A1 (en) Cell-derived vesicles engineered with anchor proteins and use thereof
KR20240010698A (ko) 앵커단백질로 엔지니어링된 세포 유래 베지클 및 이의용도

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220315

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220315

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230125

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230510

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230807